Literature DB >> 6972409

Cellular interactions affecting the maturation of murine B lymphocyte precursors in vitro.

P W Kincade, G Lee, C J Paige, M P Scheid.   

Abstract

Clonable B cells arose in liquid cultures of slg+ cell-depleted bone marrow suspensions, and a majority of these derived from rapidly sedimenting (presumably large) precursors. Such immature (pre-B) cells were not demonstrable in adult lymph nodes. The development of functional B cells in vitro depended on adherent cells present in adult bone marrow or peritoneal exudates and in the presence of optimal numbers of these accessory cells; not FCS or 2-ME or LPS were essential for B cell maturation. In contrast, the ability of fetal liver cell suspensions to generate B cells in culture was not affected by the removal of adherent cells or addition of macrophages, and LPS consistently reduced numbers of colony-forming B cells recovered. A type of nonadherent cell present in the bone marrow of adult CBA/N mice dramatically enhanced B cell maturation in normal CBA/H-T6T6 fetal liver cell cultures. These results indicate that 2 types of accessory cells may augment transition of pre-B cells to functional B cells in culture. One is adherent and can be replaced by macrophages, whereas the other is nonadherent and is present in limiting numbers in embryos. When fetal liver cultures were incubated with optimal numbers of adult accessory cells, the rate of emergence of B cells was dependent on the gestational age of the donor embryo. This suggests that B cell formation in utero may be limited by the availability of B cell precursors as well as nonadherent accessory cells. The possibility exists that fetal pre-B cells typify intermediates in the B lineage which are infrequent in adult marrow. Alternatively, B cells may be produced in adult life through processes that do not precisely recapitulate embryonic events.

Entities:  

Mesh:

Year:  1981        PMID: 6972409

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Morphologic analysis of long-term bone marrow cultures that support B-lymphopoiesis or myelopoiesis.

Authors:  K Dorshkind; L Schouest; W H Fletcher
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

2.  Tuftsin (Thr-Lys-Pro-Arg), a natural modulator of macrophage activity: further studies.

Authors:  N J Bump; V A Najjar
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

3.  Control of B cell differentiation by T cells.

Authors:  J J Mond; M E Schaefer
Journal:  Surv Immunol Res       Date:  1983

Review 4.  Pre-B cells; normal and abnormal development.

Authors:  M D Cooper
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

5.  Effects of ethanol consumption and withdrawal on B cell subpopulations in murine bone marrow.

Authors:  T E Kruger; T R Jerrells
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

6.  Beta transforming growth factors are potential regulators of B lymphopoiesis.

Authors:  G Lee; L R Ellingsworth; S Gillis; R Wall; P W Kincade
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

7.  Independent regulation of IgM, IgD, and Ia antigen expression in cultured immature B lymphocytes.

Authors:  J R Dasch; P P Jones
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

8.  One synchronous wave of B cell development in mouse fetal liver changes at day 16 of gestation from dependence to independence of a stromal cell environment.

Authors:  A Strasser; A Rolink; F Melchers
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

9.  Age-dependent deficiency of B lymphocyte lineage precursors in NZB mice.

Authors:  H Jyonouchi; P W Kincade; K S Landreth; G Lee; R A Good; M E Gershwin
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

10.  Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo.

Authors:  A Rolink; A Kudo; H Karasuyama; Y Kikuchi; F Melchers
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.